Ajanta Pharmaceuticals: Strong Performance on All Fronts
Ajanta Pharma is a focused player in branded, which constitutes ~70% of overall sales, which are spread across geographies, including India.
63 Views
Ajanta Pharmaceuticals: India Growth Drives Steady Numbers
Domestic formulations constitute 30% of the total consolidated turnover and is segregated into branded formulations & institutional business Asia...
102 Views
Ajanta Pharma: DF, US, Africa Drive Revenue Growth
Ajanta Pharma (AJP) delivered 1QFY22 earnings marginally below our expectation. Robust growth in Domestic Formulation (DF) / Branded Generics...
85 Views
HSIE Results Daily 30 July 2021: Tech Mahindra, SRF Ltd, Colgate Palmolive and More
HSIE Results Daily Tech Mahindra: We maintain a BUY rating on Tech Mahindra (TechM), based on better-than-expected revenue performance, healthy net...
113 Views
India Equity Derivatives - The Tail Wags the Dog
On April 22, the National Stock Exchange of India (NSE) published a list of 34 stocks that would be excluded from the Futures and Options segment...
539 Views